Medicine & Health

A new study by researchers at Washington University School of Medicine and St. Jude Children’s Research Hospital helps explain why mRNA vaccines have been so successful at preventing severe disease.

Researchers at Washington University School of Medicine are working to develop new treatments for two types of devastating parasitic infections common in sub-Saharan Africa and Central and South America: river blindness and intestinal worm infections.

Longtime St. Louis benefactor Joanne Knight has committed up to $11.5 million to Washington University School of Medicine in St. Louis to support an innovative clinical trial aimed at preventing Alzheimer’s disease by treating people before the first signs of the illness appear in the brain.

Researchers at Washington University School of Medicine are conducting an Alzheimer’s prevention trial with young adults from high-risk families to evaluate whether an investigational drug can clear a key Alzheimer’s protein, amyloid beta, and slow or stop the disease.

Thomas M. De Fer, MD, a nationally recognized leader in medical education, has been named director of the Division of General Medicine within the Department of Medicine at Washington University School of Medicine.

A collaboration between Washington University in St. Louis, Université de Montréal and McGill University discovers a new importance of biomolecular condensates.

Researchers at the School of Medicine were awarded $575.8 million in funding from the National Institutes of Health (NIH) in federal fiscal year 2021, according to the School of Medicine’s 2021 State of the School Report. This is an all-time high for the school.

Two research teams at Washington University — one led by Joyce Balls-Berry; the other led by Darrell Hudson and Ganesh Babulal — have received grants totaling $7 million to advance racial equity in Alzheimer’s disease research.

Researchers at Washington University School of Medicine have shown, in a small clinical trial, that pre-activated natural killer cells can help some children and young adults with recurrent acute myeloid leukemia and few other treatment options.

Asthma has been associated with a lowered risk of brain tumors, and researchers at Washington University School of Medicine now think they know why: Immune cells activated under conditions of asthma are less able to promote the growth of brain tumors.